210 related articles for article (PubMed ID: 22050860)
1. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
Lowe CR
Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
[TBL] [Abstract][Full Text] [Related]
2. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
Villoslada P; Baranzini S
J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
[TBL] [Abstract][Full Text] [Related]
3. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
4. The application of multiplexed assay systems for molecular diagnostics.
Schwarz E; VanBeveren NJ; Guest PC; Izmailov R; Bahn S
Int Rev Neurobiol; 2011; 101():259-78. PubMed ID: 22050855
[TBL] [Abstract][Full Text] [Related]
5. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market.
Bahn S; Noll R; Barnes A; Schwarz E; Guest PC
Int Rev Neurobiol; 2011; 101():299-327. PubMed ID: 22050857
[TBL] [Abstract][Full Text] [Related]
6. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
[TBL] [Abstract][Full Text] [Related]
7. General overview: biomarkers in neuroscience research.
Filiou MD; Turck CW
Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
[TBL] [Abstract][Full Text] [Related]
8. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
Ahmed MU; Saaem I; Wu PC; Brown AS
Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
[TBL] [Abstract][Full Text] [Related]
9. Future of biosensors: a personal view.
Scheller FW; Yarman A; Bachmann T; Hirsch T; Kubick S; Renneberg R; Schumacher S; Wollenberger U; Teller C; Bier FF
Adv Biochem Eng Biotechnol; 2014; 140():1-28. PubMed ID: 24196315
[TBL] [Abstract][Full Text] [Related]
10. Toward personalized medicine in the neuropsychiatric field.
Wong EH; Fox JC; Ng MY; Lee CM
Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
[TBL] [Abstract][Full Text] [Related]
11. The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.
Guest FL; Guest PC; Martins-de-Souza D
Biomark Med; 2016; 10(4):431-43. PubMed ID: 26999493
[TBL] [Abstract][Full Text] [Related]
12. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
13. [Companion diagnostics: significances and issues in its clinical application].
Miyachi H
Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
[TBL] [Abstract][Full Text] [Related]
14. [Personalized psychiatry and psychotherapy. Realistic hope for the future or fiction?].
Falkai P
Nervenarzt; 2011 Nov; 82(11):1382, 1384. PubMed ID: 22038384
[No Abstract] [Full Text] [Related]
15. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
[TBL] [Abstract][Full Text] [Related]
16. It's all about the test: the complexity of companion diagnostic co-development in personalized medicine.
Bates SE
Clin Cancer Res; 2014 Mar; 20(6):1418. PubMed ID: 24634464
[No Abstract] [Full Text] [Related]
17. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
19. [Biomarker research in neuropsychiatry: challenges and potential].
Gottschalk MG; Schwarz E; Bahn S
Fortschr Neurol Psychiatr; 2013 May; 81(5):243-9. PubMed ID: 23695789
[TBL] [Abstract][Full Text] [Related]
20. Engineering novel diagnostic modalities and implantable cytomimetic nanomaterials for next-generation medicine.
Ho D; Fung AO; Montemagno CD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):92-9. PubMed ID: 16399592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
